source
- Season 2 of The Progress Profile podcast spotlights Alzheimer’s research and patient-centered trial designThe Progress Profile: Alzheimer’s Research in Focus returns for a second season, offering conversations about Alzheimer’s disease and brain health. In the premiere episode, Dr. John Harrison, Dr.…
- Vacant lab space, shrinking workforce put Mass. in ‘unique position’ for biotech bouncebackA new report on the health of the Massachusetts biotech scene has painted a mixed picture of how drug developers are faring in the Bay State.Fierce Biotech · 13h ago↗ source
- Lilly leads GLP-1 weight-loss market while Novo Nordisk’s Wegovy exceeds expectations but falls short of forecasts